CAROL MCLEAN: Open Payments
NPI 1598988248 · CHEVERLY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,107 in 18 payments from 11 companies in 2025. Trend: 2023 $150 · 2024 $570 · 2025 $2,107
Food & beverage: $2,107
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $533 |
| Teva Pharmaceuticals USA, Inc. | 3 | $338 |
| Sage Therapeutics, LLC | 2 | $195 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $194 |
| bioMerieux Inc | 1 | $162 |
| Novo Nordisk Inc | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $123 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $122 |
| Alexion Pharmaceuticals, Inc. | 1 | $118 |
| KYOWA KIRIN, INC. | 1 | $103 |
Products named: REPATHA, Wegovy, VOQUEZNA, NEFFY, GEMTESA.
Industry payments across MD — which companies pay providers there.
